IDO1 and neoplasm: Both photosensitizer Ce6 and IDO inhibitor 1MT were encapsulated in lipid/PLGA nanocomplex (RDCM), where DSPE lipid was conjugated to peptide RGD and PD-L1 inhibitor DPPA to endow tumor targeting and PD-L1 blockade (Figure 1).